JSLL

Jeena Sikho Lifecare Limited

NSE
Last Traded Price
₹567.95 -12.5 (-2.15%)
Open
₹577.05
High
₹583.5
Low
₹565.2
Prev Close
₹580.45
Industry
Wellness
Market Cap
7059.66 Cr

Price Chart

Loading chart data...
Data delayed by up to 5 minutes. Not live.

Filing History

Recent corporate announcements and filings for JSLL

Business Update Positive
2026-07-11 15:15
- Jeena Sikho Lifecare Limited received Certificates of Appreciation from the Central Board of Indirect Taxes and Customs (CBIC). - The recognition is for prompt filing of GST returns and timely payment of Goods and Services Tax for the Financial Year 2025-26. - Certificates were received for operations in Maharashtra, Uttar Pradesh, and Haryana.
Routine Neutral
2026-06-26 15:22
- Trading window closed from July 01, 2026, for designated persons. - Closure is ahead of declaration of unaudited financial results for the quarter ended June 30, 2026. - The window will reopen 48 hours after the results are declared.
Business Update Positive
2026-06-19 22:34
- Board of Directors approved the sale of land and building for ₹9.05 Crores to M/s VSB Enterprises. - The company will continue operations from the same premises under a lease-back arrangement, ensuring no business disruption. - The asset's carrying value was ₹3.35 Crores.
Business Update Neutral
2026-06-19 22:32
- Board approved the sale of land and building for ₹9.05 Cr to M/s VSB Enterprises. The Company will lease back the asset, ensuring no disruption to business operations. This monetizes the asset without affecting continuity and is not a related party transaction.
Business Update Neutral
2026-06-17 19:04
- Concall Schedule - Concall Date: 23rd June 2026 - Concall Time: 9am-6pm - Location: Mumbai - Type of Meeting: Physical Group Meeting
Business Update Positive
2026-06-15 18:31
- Jeena Sikho Lifecare Limited executed a Memorandum of Understanding cum Research Facility Usage Agreement for a new Research Institute and Facility at Chandigarh. - The facility will focus on research, innovation, and education in Ayurveda, Integrative Healthcare, and Preventive Wellness. - The agreement is for five years (June 15, 2026, to June 14, 2031); the company will not pay rent for premises but will cover operational expenses.
Business Update Positive
2026-06-12 15:26
- Jeena Sikho Lifecare Limited is establishing a new hospital facility in Lucknow, Uttar Pradesh. - The new facility will have an estimated capacity of 160+ beds. - Estimated commencement is August 2026. - The project requires an investment of approximately ₹3 Crores, financed through internal funds.
Business Update Positive
2026-06-11 15:18
- Jeena Sikho Lifecare Limited proposes to establish a new Day Care Clinic in Ayodhya, Uttar Pradesh. - Estimated commencement: August 2026, with an area of approx 2300 sq. ft. - Investment of approximately ₹50 Lakhs, to be financed through the company's internal funds. - Objective: To expand the healthcare network and offer quality Panchakarma services.
Business Update Positive
2026-06-10 15:14
- Jeena Sikho Lifecare Limited commenced operations of its new 100-bed hospital facility, Sanskriti Ayurvedic P.G. Medical College & Hospital, in Mathura, Uttar Pradesh, effective June 10, 2026. - This expansion is expected to contribute meaningfully to the company's growth and strengthen its healthcare infrastructure.
Business Update Neutral
2026-06-09 12:47
- Concall Schedule - Concall Date: Friday, 12th June, 2026 - Concall Time: 10:00 A.M. (IST) onwards - Event: Investor/Analyst Group Meeting at Choice Institutional Equities- InsightX Virtual Forum
Business Update Positive
2026-06-08 16:38
- FY26 Revenue from Operations grew 71% YoY to INR801 crores; Q4 FY26 Revenue grew 55% YoY to INR216 crores. - FY26 EBITDA grew 149% YoY to INR349 crores with a 44% margin (up 1360 bps YoY); Q4 FY26 EBITDA grew 70% YoY to INR78 crores with a 36% margin. - FY26 PAT grew 177% YoY to INR222 crores with a 28% margin; Q4 FY26 PAT grew 79% YoY to INR45 crores. - Q4 FY26 earnings decline QoQ attributed to approximately INR19-20 crores in one-time non-recurring provisions and geopolitical events affecting advance bookings. - Management targets a minimum PAT of INR300 crores for FY27 and 4x-5x PAT growth in the next 3-5 years, with a revenue target of INR3000 crores. - Operational beds are planned to increase from 2,300 to 3,000 in the next 3-4 months, aiming for 7,000-10,000 beds in 3-5 years. - New products for female/male wellness, pregnancy, and chronic diseases are launching in June/July, alongside expansion into new luxury and 4-star wellness centers.
Business Update Positive
2026-06-03 17:09
- Jeena Sikho Lifecare Limited received NABH Accreditation for its hospital in Bhopal, Madhya Pradesh. - The accreditation is for 'Panchakarma' services and is valid until May 04, 2029, signifying adherence to national quality standards.
Business Update Neutral
2026-06-02 18:04
- Audio recording of the Earnings Conference Call held on June 02, 2026, to discuss Q4 and FY ended March 31, 2026, financial results is now available on the company's website.
Financials Positive
2026-06-01 16:56
Consolidated Revenue ₹233.13 Cr vs ₹172.95 Cr (▲34.8% YoY), EBITDA ₹30.98 Cr vs ₹21.35 Cr (▲45.2% YoY), PAT ₹23.02 Cr vs ₹15.86 Cr (▲45.1% YoY). EBITDA Margin 13.3% vs 12.3% (▲96bps).
Financials Positive
2026-05-30 18:58
The Board of Directors of Jeena Sikho Lifecare Limited approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026, with an unmodified audit opinion. The board also recommended a final dividend of Rs. 4.50/- per equity share for the financial year 2025-26, subject to shareholder approval. Additionally, M/s Forvis Mazars LLP was re-appointed as the Internal Auditor for FY 2026-27.
Financials Positive
2026-05-30 18:41
Jeena Sikho Lifecare Limited reported robust Q4 FY26 consolidated financial performance with Revenue from Operations at ₹215.55 Cr compared to ₹139.25 Cr in Q4 FY25, marking a 54.79% YoY increase. EBITDA grew by 70.24% YoY to ₹77.92 Cr from ₹45.77 Cr, with EBITDA Margin expanding by 328 bps to 36.15% from 32.87%. Net Profit (PAT) surged by 77.89% YoY to ₹45.08 Cr from ₹25.34 Cr. The Board recommended a final dividend of Rs. 4.50 per equity share for the financial year 2025-26.
Financials Positive
2026-05-30 18:41
The Board of Directors of Jeena Sikho Lifecare Limited approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026, which received an unmodified audit opinion. The board recommended a final dividend of Rs. 4.50/- per equity share for the financial year 2025-26, subject to shareholder approval. M/s Forvis Mazars LLP was also re-appointed as the Internal Auditor for FY 2026-27.
Financials Positive
2026-05-30 18:41
Jeena Sikho Lifecare Limited's Board of Directors approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026, with an unmodified audit opinion. The Board also recommended a final dividend of Rs. 4.50/- per equity share for FY 2025-26, subject to shareholder approval. Additionally, M/s Forvis Mazars LLP was re-appointed as the Internal Auditor for FY 2026-27.
Business Update Neutral
2026-05-27 18:02
Jeena Sikho Lifecare Limited announced an Earnings Conference Call for Investors and Analysts for Q4 FY26 audited financial results. The call is scheduled for Tuesday, 02nd June, 2026, at 01:30 P.M. IST and will feature Mr. Manish Grover (Managing Director) and Mr. Nanak Chand (Chief Financial Officer).
Business Update Positive
2026-05-25 19:20
Jeena Sikho Lifecare Limited announced on May 25, 2026, the publication of multiple case studies and reports authored by its associated medical professionals in international journals. These publications demonstrate the Company's ongoing commitment to Ayurvedic research and evidence-based clinical practice, covering various health conditions like chronic kidney disease, gastrointestinal stromal tumor, and female infertility.
Business Update Positive
2026-05-09 18:45
Jeena Sikho Lifecare Limited's Board approved the sale of approximately 48 Bigha of non-operational land in Patiala, Punjab, to Tresco Realty Group LLP for ₹24,00,00,000 (Twenty-Four Crores). The company stated the sale will have no impact on its business operations as the land was not used for business activities, and the transaction is not a related party transaction, effectively freeing up capital from a non-core asset.
Business Update Positive
2026-05-08 17:56
Jeena Sikho Lifecare Limited's Board approved the sale of approximately 48 Bigha of non-operational land in Punjab to Tresco Realty Group LLP for ₹24,00,00,000/- (Twenty-Four Crores Only). The company stated that the sale will not impact its core business operations as the land was non-operational.
Routine Neutral
2026-05-04 20:29
New Filing detected. See link for details.
Business Update Positive
2026-05-04 19:18
Jeena Sikho Lifecare Limited announced on May 4, 2026, the publication of seven case studies and two case reports authored by its associated medical professionals, including the Managing Director, in the 'Journal of Applied Science and Education (JASE)'. These publications demonstrate the Company's commitment to Ayurvedic research and evidence-based clinical practice, covering conditions like chronic kidney disease, sciatica, osteoarthritis, and liver cirrhosis.
Business Update Positive
2026-04-15 17:24
Jeena Sikho Lifecare Limited's Noida Hospital received NABH Accreditation (AH-2026-0451), valid until March 9, 2029. This signifies adherence to nationally recognized quality healthcare standards, enhancing patient safety and operational excellence.
Business Update Positive
2026-04-14 23:30
Jeena Sikho Lifecare Limited signed a Strategic MOU with Sat Kartar Life Limited on April 14, 2026. This collaboration aims to integrate patient acquisition with Jeena Sikho's healthcare infrastructure for enhanced efficiency and patient outcomes, and develop Ayurveda hospitals. It includes a 15% revenue share for SKL.
Routine Neutral
2026-03-23 13:40
Jeena Sikho Lifecare Limited announced the closure of the trading window for Designated Persons and their immediate relatives from April 01, 2026, until 48 hours after the declaration of Audited Financial Results for the Quarter and Financial Year ended March 31, 2026.
Business Update Positive
2026-03-23 12:31
Jeena Sikho Lifecare Limited announced the publication of three academic case studies/reports on Ayurvedic management of chronic liver disease, kidney disease, and prostatomegaly in the "International Journal of Advanced Research (IJAR)" on March 23, 2026, showcasing its commitment to Ayurvedic research and evidence-based clinical practice.
Business Update Neutral
2026-03-17 16:00
Jeena Sikho Lifecare Limited announced an Investor/Analyst Meet on March 23, 2026, at Trident, BKC, Mumbai. Managing Director Mr. Manish Grover and Dr. Ish Sharma will meet institutional investors in a physical group meeting organized by DAM capital.
Governance Neutral
2026-03-09 12:34
Jeena Sikho Lifecare Limited's Board on March 09, 2026, approved amendments to its Code of Fair Disclosure and Insider Trading Policy as per SEBI PIT Regulations, 2015. The updated code will be available on the company website.
Business Update Neutral
2026-03-06 17:31
Jeena Sikho Lifecare Limited announced its Managing Director, CFO, and Dr. Ish Sharma will participate virtually in the Arihant Capital Bharat Connect Conference- Rising Stars 2026 on March 11, 2026. No unpublished price sensitive information will be shared.
Business Update Positive
2026-02-23 14:37
Jeena Sikho Lifecare Limited announced the publication of five (5) case studies and one (1) case report authored by their medical professionals in the "International Journal of Advanced Research (IJAR)" and the "Journal of Ayurveda and Integrated Medical Sciences (JAIMS)", showcasing their commitment to Ayurvedic research and evidence-based clinical practice.
Business Update Positive
2026-02-19 13:21
Jeena Sikho Lifecare Limited has received the National Accreditation Board for Hospitals & Healthcare Providers (NABH) Certificate of Accreditation for its Dehradun Hospital, specifically for Panchakarma services. This accreditation signifies adherence to nationally recognized standards for quality healthcare delivery and operational excellence, valid until January 2029.
Business Update Positive
2026-02-16 18:46
Jeena Sikho Lifecare Limited announced establishing a new 150-bed hospital unit in Ahmedabad, Gujarat, with an estimated investment of ₹1.5 Crore. The unit is expected to commence operations within 6 months, strengthening the company's presence and healthcare services.
Financials Positive
2026-02-13 16:38
Consolidated Revenue ₹221.7Cr vs ₹115.47Cr (▲92% YoY), EBITDA ₹100.8Cr vs ₹29.65Cr (▲240% YoY), PAT ₹66.7Cr vs ₹13.21Cr (▲405% YoY). EBITDA Margin 45% vs 25.68% (▲1932bps).
Financials Positive
2026-02-10 12:25
Consolidated Revenue ₹221.68Cr vs ₹115.69Cr (▲92% YoY), EBITDA ₹100.72Cr vs ₹29.61Cr (▲240% YoY), PAT ₹66.60Cr vs ₹13.21Cr (▲404% YoY). EBITDA Margin 45.44% vs 25.59% (▲1985bps).
Business Update Neutral
2026-02-09 19:25
Jeena Sikho Lifecare Limited submitted the audio recording of its Earnings Conference Call for Q3 FY 2025-26, held on February 9, 2026. The recording, which discusses the financial results for the quarter ended December 31, 2025, is available on the company's website.
Financials Neutral
2026-02-08 14:26
Jeena Sikho Lifecare Limited submitted its Investor Presentation for Q3 FY26 financial performance on February 08, 2026. This presentation, enclosed with the filing, was discussed in a conference call on February 04, 2026, and is being used for investor meetings scheduled for February 09, 2026.
Financials Positive
2026-02-07 19:06
Consolidated Revenue ₹221.68Cr vs ₹115.69Cr (▲91.6% YoY), EBITDA ₹103.29Cr vs ₹30.00Cr (▲244.3% YoY), PAT ₹66.60Cr vs ₹13.21Cr (▲404.1% YoY). EBITDA Margin 46.6% vs 25.9% (▲2066bps).
Financials Neutral
2026-02-07 18:56
The Board of Directors of Jeena Sikho Lifecare Limited approved the unaudited standalone and consolidated financial results for the quarter and nine months ended 31st December 2025 at its meeting held on February 7, 2026. The actual financial figures are not provided in this filing.
Business Update Positive
2026-01-22 13:18
Jeena Sikho Lifecare Limited announced the publication of a case report in 'Ayush Journal of Integrative Oncology' on Jan 22, 2026. The report details a post-mastectomy breast cancer survivor's one-year disease-free resolution via Ayurvedic interventions, showcasing the company's commitment to evidence-based clinical practices.
Business Update Negative
2026-01-21 19:23
CRITICAL RED FLAG DETECTED
Board approved an unsecured loan of AED 7.53 million (8.5% interest, 5-year tenure) to its wholly-owned subsidiary, Jeena Sikho International LLC, for business needs. The Board also noted and paid fines imposed by NSE/BSE for non-compliance with SEBI regulations, implementing corrective measures.
Ownership Positive
2026-01-16 17:12
Jeena Sikho Lifecare Limited announced the acquisition of a 51% equity stake in Back to Roots Ayurveda by Dr. Shyam LLC, Abu Dhabi, UAE for 1,530,000 Dirhams. The acquisition aims to strengthen their Ayurveda and wellness segment.
Routine Neutral
2026-01-13 13:37
Jeena Sikho Lifecare Limited entered into a Procurement Agreement with Theryco Healthcare Solutions on January 3rd, 2026, to list and sell products on Amazon. The agreement is not a related party transaction.
Routine Neutral
2026-01-12 14:35
Jeena Sikho Lifecare Limited published case studies and a research article in European and International Journals on Ayurvedic management of Type 2 Diabetes and Chronic Kidney Disease (dated Jan 12, 2026).
Routine Neutral
2026-01-07 16:14
Jeena Sikho Lifecare published 9 case studies and reports on Ayurvedic treatments in various journals | Dated January 7, 2026.

Unlock Full History

Log in to view all historical filings for JSLL and get instant Telegram alerts when new announcements drop.

Login with Telegram